Total Payments
$1,047
2024 Payments
$825.90
Companies
11
Transactions
58
Payment Breakdown by Category
Food & Beverage$1,047 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,047 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $234.38 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $192.40 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $150.41 | 6 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $117.11 | 7 | $0 (2024) |
| Alkermes, Inc. | $103.33 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $63.25 | 3 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $57.27 | 3 | $0 (2024) |
| Corium, LLC | $37.00 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $34.86 | 2 | $0 (2024) |
| Lundbeck LLC | $33.63 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $825.90 | 47 | ABBVIE INC. ($212.96) |
| 2023 | $221.04 | 11 | Teva Pharmaceuticals USA, Inc. ($105.23) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Neuropsychiatry | ||||||
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Neuropsychiatry | ||||||
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: PSYCHIATRY | ||||||
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: PSYCHIATRY | ||||||
| 02/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Neuropsychiatry | ||||||
| 02/14/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Central Nervous System | ||||||
| 02/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: NEUROLOGY | ||||||
| 01/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/09/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: PSYCHOLOGY | ||||||
About David Yuna
David Yuna is a Family Medicine healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1164958583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Yuna has received a total of $1,047 in payments from pharmaceutical and medical device companies, with $825.90 received in 2024. These payments were reported across 58 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,047).
Ad
Practice Information
- Specialty Family Medicine
- Location Latrobe, PA
- Active Since 05/04/2017
- Last Updated 05/04/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164958583
Products in Payments
- VRAYLAR (Drug) $234.38
- REXULTI (Drug) $160.86
- INGREZZA (Drug) $117.11
- Austedo XR (Drug) $106.46
- LYBALVI (Drug) $76.22
- CAPLYTA (Drug) $63.25
- UZEDY (Drug) $43.95
- Azstarys (Drug) $37.00
- Auvelity (Drug) $34.86
- QELBREE (Drug) $31.26
- ARISTADA (Drug) $27.11
- NUEDEXTA (Drug) $26.78
- Qelbree (Drug) $26.01
- HETLIOZ (Drug) $23.30
- ABILIFY ASIMTUFII (Drug) $20.50
- ABILIFY MAINTENA (Drug) $17.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Latrobe
Steven Selip, Md, MD
Family Medicine — Payments: $2,187
Family Medicine $2,187
Matthew Woleslagle, D.o, D.O
Family Medicine — Payments: $1,682
Family Medicine $1,682
Dr. Lindsey Beabout, D.o, D.O
Family Medicine — Payments: $1,542
Family Medicine $1,542
David Ream, Md, MD
Family Medicine — Payments: $761.53
Family Medicine $761.53
Dr. Justin Mccray, M.d, M.D
Family Medicine — Payments: $368.00
Family Medicine $368.00
Donald Jakubek, Md, MD
Family Medicine — Payments: $350.24
Family Medicine $350.24